Profound Medical forecasts Q3 revenue above estimates
Profound Medical said it expects third-quarter revenue above Wall Street estimates, citing commercial strength. Shares rose 23% to $6.97 in premarket trading.
Profound Medical said it expects third-quarter revenue above Wall Street estimates, pointing to commercial strength. 97 in premarket trading on Thursday. At Wednesday's close, the stock was down 28% year to date.